Background There is a considerable amount of practice variation in managing migraines in
emergency settings, and evidence-based therapies are often not used first line. Methods A …

Allodynia, the perception of pain induced by a non-painful stimulus, is frequently associated
with migraine, especially when chronic, and mainly in the aura subtype. Among migraineurs …

The objective and background is to confirm in a double-blind, placebo-controlled study the
high triptan response rates we had previously reported in an open study in migraine patients …

There is evidence that the prevalence of migraine in children and adolescents may be
increasing. Current theories of migraine pathophysiology in adults suggest activation of …

Background The marketing of sumatriptan, a selective serotonin (5-HT) 1B/1D agonist, first
of the class of triptans, has increased the therapeutic options for the treatment of migraine …

Objective.—To evaluate the relationship between treatment outcomes and allodynia‐
associated symptoms (AAS) at the time of treatment with almotriptan. Methods.—Analyses …

To describe the functional profiles of patients with migraine, and the relationships between
symptoms, activities and environmental factors, using WHO's International Classification of …

Over the last 10 years, triptans (serotonin 5-HT1B/1D receptor agonists) have proved to be
efficacious in treating migraine pain. However, recent evidence suggests that patients are …

Migraine is a common neurovascular disorder, affecting millions of people worldwide.
Current guidelines recommend triptans as first-line treatment for moderate-to-severe …

Background It is generally felt that patient education and patient knowledge regarding triptan
use for acute migraine management are important for successful and safe treatment. It is …